Trials / Unknown
UnknownNCT06218043
An Iodine Balance Study to Investigate the Recommended Iodine Intake in an Elderly Population
An Iodine Balance Study in the Elderly
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Wenxing Guo · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Current Chinese dietary iodine reference intake (DRIs) standards lack direct data on recommended iodine intake (RNI) in the elderly. The elderly have a high prevalence of thyroid diseases. The risk threshold of iodine intake in the elderly is unknown. Identifying the appropriate iodine intake for the elderly to maintain optimal thyroid function to reduce the burden on medical resources is a public health issue requiring high attention. The iodine balance study is an important method for exploring physiological iodine requirements. Few iodine balance studies have been conducted in the elderly. This study aimed to conduct an iodine balance study and provide information on the appropriate iodine intake level for elderly people.
Detailed description
The investigators measured subjects' food and water intake throughout the day using weighing methods, and collected all urine and fecal samples. Food, drinking water, fecal and urine samples were taken to determine iodine concentrations. Each subject was required to participate in two phases of iodine balance studies. Each stage lasts 4 to 10 days. There was no intervention in the first half of the experiment, and there was an intervention of iodized salt/non-iodized salt consumption in the second half of the experiment. The appropriate level of iodine intake for the elderly was explored by fitting and analyzing the dose change relationship between iodine intake and iodine excretion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Restrict subjects' intake of iodine-containing foods | Replace subjects' iodized salt with non-iodized salt. |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2025-06-30
- Completion
- 2025-12-31
- First posted
- 2024-01-23
- Last updated
- 2024-01-23
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06218043. Inclusion in this directory is not an endorsement.